SlideShare uma empresa Scribd logo
1 de 28
   BY : SHAVYA SINGH
 M.PHARM
    (PHARMACOLOGY)
   1ST YEAR
 1930s,  first developed by A.Wilhelm
  Tiselius-a swedish biochemist, won the
  Nobel Prize in 1948.
 Used to study enzymes and other
  proteins.
 Relies on the affinity of various
  biochemical compounds with specific
  properties.
Affinity
        Chromatography




Bio-specific     Chemo-specific
   The matrix simply provides a structure to increase
    the surface area to which the molecule can bind.



   The matrix must be activated for the ligand to bind
    to it but still able to retain it’s own activation
    towards the target molecule.
   Amino, hydroxyl, carbonyl and thio groups located
    with the matrix serve as ligand binding sites.

   Matrix are made up of agarose and other
    polysaccharides

   The matrix also must be able to withstand the
    decontamination process of rinsing with sodium
    hydroxide or urea.
   Cellulose : used for DNA affinity
    chromatography.


 Polyacrylamite : it exist in gel & in form of
  beads. The beads form are not
  sufficiently porous, so it do not allow
  ligand to bind over that.
 Agarose
 It is having higher separation ability.
 It is found to be non-biodegradable.
 It has small particle size 40-80
  micrometer.
 It can be derivetized.
 Commercially known by spheron beads.
LIGAND



SPECIFIC   GROUP
LIGAND     LIGAND
   The Ligand binds only to the desired molecule within the
    solution

   The ligand attaches to the matrix which is made up of an
    inert substance

   The ligand should only interact with the desired molecule and
    form a temporary bond

   The ligand/molecule complex will remain in the column,
    eluting everything else off

   The ligand/molecule complex dissociates by changing the
    pH
• Antigen        Antibody

• Antibody        Antigen

• Substrate       Enzyme

• DNA             Histon

• Hormone     Binding Protein/Receptor
   1) Inject a sample into an initially equilibrated affinity
    chromatography column.
   2) Only the substances with affinity for the ligand are
    retained in the column.
   3) Other substances with no affinity for the ligand are
    eluted from the column.
   4) The substances retained in the column can be
    eluted from the column by changing pH or salt or
    organic solvent concentration of the eluent.
    Affinity chromatography is widely used as a means of
    separation and purification with specific properties.
   Specificity is based on three aspect of
    affinity

             Matrix: for ligand attachment.



         Spacer arm: used to bind ligand to matrix



         Ligand: molecule that binds reversibly to a specific
           target molecule(site of interaction)
   Hi-Trap Heparin HP (High performance)

 Column size: 5 × 1 mm 1 × 5 mm 5 × 5
  mm
 Average particle diameter : 34μm
 Maximum operating flow rate: 4 ml/min
  20 ml/min.
 At 2-8 °C in an upright position with both
  caps in place.
 Thio-mersal may be added for long term
  storage.
 DO NOT FREEZE
 Application areas : purification, isolation
  or removal of the following substances:
  Anti-thrombin III and other coagulation
  factors, lipoproteins, lipases, protein
  synthesis factors
   :Step-1 Attach ligand to column matrix

    Binding of the selected ligand to the
    matrix requires that a covalent bond be
    formed between the two.
   This is facilitated by derivatization of the
    sugar residues' hydroxyl groups.

   It is important to realize that the substrate
    might not be able to reach the ligand
    active site if it is hidden deep within the
    ligand.

   Most ligands are attached first to spacer
    arms which are then bonded to the
    matrix. The ligand-matrix gel is then
    loaded into an elution column.
 Once the column has been
  prepared, the mixture containing
  isolate is poured into the elution
  column.
 Gravity pulls the solution through
  the gel, because most of the
  proteins do not bind to the
  ligand-matrix complex.
 When ligand is recognized
  substrate passes through the gel,
  it binds to the ligand-matrix
  complex, halting its passage
  through the gel.
 Some of the impurities flow
  through the gel due to gravity,
  but most remain, unbound, in the
  gel column
    In order to remove these
    unbound impurities, a wash
    of extreme pH, salt
    concentration, or
    temperature is run through
    the gel.
    It is important to use a
    strong wash so that all the
    impurities are removed.
   Once the impurities are
    washed-out, the only
    remaining part of the protein
    mixture should be the
    desired isolates.
   Finally to collect isolate,
    which is still bound to the
    ligand-matrix in the gel, a
    stronger second wash is
    run through the column.
   This second wash
    relies on the
    reversible binding
    properties of the
    ligand, which allows
    the bound protein to
    dissociate from its
    ligand in the
    presence of this
    stronger wash.
   The protein is then
    free to run through
    the gel and be
    collected.
 Purify and concentrate a substance from a
  mixture into a buffering solution.
 Reduce the amount of a substance in a
  mixture.
 Purify and concentrate an enzyme solution.
 Used   in Genetic Engineering
     - nucleic acid purification
 Production of Vaccines
     - antibody purification from blood
  serum
 And Basic Metabolic Research
     - protein or enzyme purification from
  cell free extracts
 Affinity chromatography is widely used in
  the pharmaceutical industry to purify and
  extract molecules of interest from complex
  mixtures.
 These molecules tend to be enzymes,
  proteins or amino acids, but other
  biological species can be selectively
  retained.
 Once isolated, these biological species can
  be selectively amplified to produce larger
  quantities, although at large
  concentrations.
   Hyper-lipidemia : here the sample is made
    to pass through coloumn containing
    antibody & plasma LDL so, it can easily be
    separated out by iluting with glycine
    hydrochloride buffer (pH 3).
   Others :
   Pregnancy test
   Allergy test
   Immuno assay
   Kinetic studies
   Qualitative measurment of substrate.
1) Extremely high specificity
2) High degrees of purity can be obtained
3) The process is very reproducible
4) The binding sites of biological molecules
   can be simply investigated
1) Expensive ligands
2) Leakage of ligand
3) Degradation of the solid support
4) Limited lifetime
5) Non-specific adsorption
6) Relatively low productivity
Affinity chromatography

Mais conteúdo relacionado

Mais procurados

Mais procurados (20)

GEL CHROMATOGRAPHY
GEL CHROMATOGRAPHYGEL CHROMATOGRAPHY
GEL CHROMATOGRAPHY
 
Affinity chromatography ppt
Affinity chromatography pptAffinity chromatography ppt
Affinity chromatography ppt
 
Affinity chromatography
Affinity chromatography Affinity chromatography
Affinity chromatography
 
Affinity chromatography by Shiv kalia ( m.pharma analytical chemistry)
Affinity chromatography by Shiv kalia ( m.pharma   analytical chemistry)Affinity chromatography by Shiv kalia ( m.pharma   analytical chemistry)
Affinity chromatography by Shiv kalia ( m.pharma analytical chemistry)
 
Plate theory of Chromatography
Plate theory of ChromatographyPlate theory of Chromatography
Plate theory of Chromatography
 
Ion Exchange Chromatography, ppt
Ion Exchange Chromatography, pptIon Exchange Chromatography, ppt
Ion Exchange Chromatography, ppt
 
Ion exchange chromatography
Ion exchange chromatography Ion exchange chromatography
Ion exchange chromatography
 
Van deemter equation
Van deemter equationVan deemter equation
Van deemter equation
 
Ion exchange chromatography PPT.
Ion exchange chromatography PPT.Ion exchange chromatography PPT.
Ion exchange chromatography PPT.
 
Ion exchange chromatography
Ion exchange chromatographyIon exchange chromatography
Ion exchange chromatography
 
ION EXCHANGE CHROMATOGRAPHY
ION EXCHANGE CHROMATOGRAPHYION EXCHANGE CHROMATOGRAPHY
ION EXCHANGE CHROMATOGRAPHY
 
HPLC
HPLCHPLC
HPLC
 
Ion exchange chromatography
Ion  exchange chromatographyIon  exchange chromatography
Ion exchange chromatography
 
AFFINITY CHROMATOGRAPHY
AFFINITY CHROMATOGRAPHYAFFINITY CHROMATOGRAPHY
AFFINITY CHROMATOGRAPHY
 
thin layer chromatography
thin layer chromatographythin layer chromatography
thin layer chromatography
 
Lc ms
Lc msLc ms
Lc ms
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatography
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatography
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatography
 
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY (HPLC)
 

Semelhante a Affinity chromatography

affinitychromatography.pptx
affinitychromatography.pptxaffinitychromatography.pptx
affinitychromatography.pptxKhemBhattarai
 
affinity..,.,..pptx
affinity..,.,..pptxaffinity..,.,..pptx
affinity..,.,..pptxNavamiSunil3
 
Affinity Chromatography.pptx
Affinity Chromatography.pptxAffinity Chromatography.pptx
Affinity Chromatography.pptxJaibhagwan47
 
Pharmaceutical analysis & qc ii - SAM
Pharmaceutical analysis & qc ii - SAMPharmaceutical analysis & qc ii - SAM
Pharmaceutical analysis & qc ii - SAMSamya Sayantan
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatographyRekha T N
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatographyBhuma Dhinchak
 
Affinity Chromatography MP MPAT Presentation.pptx
Affinity Chromatography MP MPAT Presentation.pptxAffinity Chromatography MP MPAT Presentation.pptx
Affinity Chromatography MP MPAT Presentation.pptxKartik Tiwari
 
Affinity Chromatography.pdf
Affinity Chromatography.pdfAffinity Chromatography.pdf
Affinity Chromatography.pdfMohiniTawade
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatographyNADIRHASSAN10
 
Affinity Chromatography. principle, instrumentation
Affinity Chromatography. principle, instrumentationAffinity Chromatography. principle, instrumentation
Affinity Chromatography. principle, instrumentationDr. Vijaya Barge
 
Affinity chromatography AND tissue plasminogen activator
Affinity chromatography AND tissue plasminogen activatorAffinity chromatography AND tissue plasminogen activator
Affinity chromatography AND tissue plasminogen activatorPramod Pal
 
Affinity chromatography and gel filteration
Affinity chromatography and gel filterationAffinity chromatography and gel filteration
Affinity chromatography and gel filterationAshfaq Ahmad
 
Affinity chromatography by Mr. Vinayak B
Affinity chromatography by Mr. Vinayak BAffinity chromatography by Mr. Vinayak B
Affinity chromatography by Mr. Vinayak BMayur Bodhankar
 
Affinity chromatography.pptx
Affinity chromatography.pptxAffinity chromatography.pptx
Affinity chromatography.pptxumeshsonawane1362
 
Affinity Chromoatograpy
Affinity ChromoatograpyAffinity Chromoatograpy
Affinity ChromoatograpyNaresh sah
 
Affinty chromatography (1).ppt
Affinty chromatography (1).pptAffinty chromatography (1).ppt
Affinty chromatography (1).pptARIBAKHAN58
 
AFFINITY chromatography.pptx
AFFINITY chromatography.pptxAFFINITY chromatography.pptx
AFFINITY chromatography.pptxDoyelMukherjee8
 

Semelhante a Affinity chromatography (20)

Affinity chromatography.pdf
Affinity chromatography.pdfAffinity chromatography.pdf
Affinity chromatography.pdf
 
affinitychromatography.pptx
affinitychromatography.pptxaffinitychromatography.pptx
affinitychromatography.pptx
 
affinity..,.,..pptx
affinity..,.,..pptxaffinity..,.,..pptx
affinity..,.,..pptx
 
Affinity Chromatography.pptx
Affinity Chromatography.pptxAffinity Chromatography.pptx
Affinity Chromatography.pptx
 
Affinity Chromatography.pptx
Affinity Chromatography.pptxAffinity Chromatography.pptx
Affinity Chromatography.pptx
 
Pharmaceutical analysis & qc ii - SAM
Pharmaceutical analysis & qc ii - SAMPharmaceutical analysis & qc ii - SAM
Pharmaceutical analysis & qc ii - SAM
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatography
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatography
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatography
 
Affinity Chromatography MP MPAT Presentation.pptx
Affinity Chromatography MP MPAT Presentation.pptxAffinity Chromatography MP MPAT Presentation.pptx
Affinity Chromatography MP MPAT Presentation.pptx
 
Affinity Chromatography.pdf
Affinity Chromatography.pdfAffinity Chromatography.pdf
Affinity Chromatography.pdf
 
Affinity chromatography
Affinity chromatographyAffinity chromatography
Affinity chromatography
 
Affinity Chromatography. principle, instrumentation
Affinity Chromatography. principle, instrumentationAffinity Chromatography. principle, instrumentation
Affinity Chromatography. principle, instrumentation
 
Affinity chromatography AND tissue plasminogen activator
Affinity chromatography AND tissue plasminogen activatorAffinity chromatography AND tissue plasminogen activator
Affinity chromatography AND tissue plasminogen activator
 
Affinity chromatography and gel filteration
Affinity chromatography and gel filterationAffinity chromatography and gel filteration
Affinity chromatography and gel filteration
 
Affinity chromatography by Mr. Vinayak B
Affinity chromatography by Mr. Vinayak BAffinity chromatography by Mr. Vinayak B
Affinity chromatography by Mr. Vinayak B
 
Affinity chromatography.pptx
Affinity chromatography.pptxAffinity chromatography.pptx
Affinity chromatography.pptx
 
Affinity Chromoatograpy
Affinity ChromoatograpyAffinity Chromoatograpy
Affinity Chromoatograpy
 
Affinty chromatography (1).ppt
Affinty chromatography (1).pptAffinty chromatography (1).ppt
Affinty chromatography (1).ppt
 
AFFINITY chromatography.pptx
AFFINITY chromatography.pptxAFFINITY chromatography.pptx
AFFINITY chromatography.pptx
 

Affinity chromatography

  • 1. BY : SHAVYA SINGH  M.PHARM (PHARMACOLOGY)  1ST YEAR
  • 2.  1930s, first developed by A.Wilhelm Tiselius-a swedish biochemist, won the Nobel Prize in 1948.  Used to study enzymes and other proteins.  Relies on the affinity of various biochemical compounds with specific properties.
  • 3. Affinity Chromatography Bio-specific Chemo-specific
  • 4. The matrix simply provides a structure to increase the surface area to which the molecule can bind.  The matrix must be activated for the ligand to bind to it but still able to retain it’s own activation towards the target molecule.
  • 5. Amino, hydroxyl, carbonyl and thio groups located with the matrix serve as ligand binding sites.  Matrix are made up of agarose and other polysaccharides  The matrix also must be able to withstand the decontamination process of rinsing with sodium hydroxide or urea.
  • 6. Cellulose : used for DNA affinity chromatography.  Polyacrylamite : it exist in gel & in form of beads. The beads form are not sufficiently porous, so it do not allow ligand to bind over that.  Agarose
  • 7.  It is having higher separation ability.  It is found to be non-biodegradable.  It has small particle size 40-80 micrometer.  It can be derivetized.  Commercially known by spheron beads.
  • 8. LIGAND SPECIFIC GROUP LIGAND LIGAND
  • 9. The Ligand binds only to the desired molecule within the solution  The ligand attaches to the matrix which is made up of an inert substance  The ligand should only interact with the desired molecule and form a temporary bond  The ligand/molecule complex will remain in the column, eluting everything else off  The ligand/molecule complex dissociates by changing the pH
  • 10. • Antigen Antibody • Antibody Antigen • Substrate Enzyme • DNA Histon • Hormone Binding Protein/Receptor
  • 11.
  • 12. 1) Inject a sample into an initially equilibrated affinity chromatography column.  2) Only the substances with affinity for the ligand are retained in the column.  3) Other substances with no affinity for the ligand are eluted from the column.  4) The substances retained in the column can be eluted from the column by changing pH or salt or organic solvent concentration of the eluent. Affinity chromatography is widely used as a means of separation and purification with specific properties.
  • 13. Specificity is based on three aspect of affinity Matrix: for ligand attachment. Spacer arm: used to bind ligand to matrix Ligand: molecule that binds reversibly to a specific target molecule(site of interaction)
  • 14. Hi-Trap Heparin HP (High performance)  Column size: 5 × 1 mm 1 × 5 mm 5 × 5 mm  Average particle diameter : 34μm  Maximum operating flow rate: 4 ml/min 20 ml/min.
  • 15.  At 2-8 °C in an upright position with both caps in place.  Thio-mersal may be added for long term storage.  DO NOT FREEZE  Application areas : purification, isolation or removal of the following substances: Anti-thrombin III and other coagulation factors, lipoproteins, lipases, protein synthesis factors
  • 16. :Step-1 Attach ligand to column matrix  Binding of the selected ligand to the matrix requires that a covalent bond be formed between the two.  This is facilitated by derivatization of the sugar residues' hydroxyl groups.  It is important to realize that the substrate might not be able to reach the ligand active site if it is hidden deep within the ligand.  Most ligands are attached first to spacer arms which are then bonded to the matrix. The ligand-matrix gel is then loaded into an elution column.
  • 17.  Once the column has been prepared, the mixture containing isolate is poured into the elution column.  Gravity pulls the solution through the gel, because most of the proteins do not bind to the ligand-matrix complex.  When ligand is recognized substrate passes through the gel, it binds to the ligand-matrix complex, halting its passage through the gel.  Some of the impurities flow through the gel due to gravity, but most remain, unbound, in the gel column
  • 18. In order to remove these unbound impurities, a wash of extreme pH, salt concentration, or temperature is run through the gel.  It is important to use a strong wash so that all the impurities are removed.  Once the impurities are washed-out, the only remaining part of the protein mixture should be the desired isolates.
  • 19. Finally to collect isolate, which is still bound to the ligand-matrix in the gel, a stronger second wash is run through the column.
  • 20. This second wash relies on the reversible binding properties of the ligand, which allows the bound protein to dissociate from its ligand in the presence of this stronger wash.
  • 21. The protein is then free to run through the gel and be collected.
  • 22.  Purify and concentrate a substance from a mixture into a buffering solution.  Reduce the amount of a substance in a mixture.  Purify and concentrate an enzyme solution.
  • 23.  Used in Genetic Engineering - nucleic acid purification  Production of Vaccines - antibody purification from blood serum  And Basic Metabolic Research - protein or enzyme purification from cell free extracts
  • 24.  Affinity chromatography is widely used in the pharmaceutical industry to purify and extract molecules of interest from complex mixtures.  These molecules tend to be enzymes, proteins or amino acids, but other biological species can be selectively retained.  Once isolated, these biological species can be selectively amplified to produce larger quantities, although at large concentrations.
  • 25. Hyper-lipidemia : here the sample is made to pass through coloumn containing antibody & plasma LDL so, it can easily be separated out by iluting with glycine hydrochloride buffer (pH 3).  Others :  Pregnancy test  Allergy test  Immuno assay  Kinetic studies  Qualitative measurment of substrate.
  • 26. 1) Extremely high specificity 2) High degrees of purity can be obtained 3) The process is very reproducible 4) The binding sites of biological molecules can be simply investigated
  • 27. 1) Expensive ligands 2) Leakage of ligand 3) Degradation of the solid support 4) Limited lifetime 5) Non-specific adsorption 6) Relatively low productivity